Delta Will Be The Dominant Variant Of Covid-19 For Months, Says WHO.

Geneva, Switzerland – The highly contagious Delta version of Covid-19 is expected to become the dominant strain of the virus in the coming months, the World Health Organization said Wednesday.

First discovered in India, the Delta is now registered in 124 regions – 13 more than last week – and now accounts for more than three-quarters of specimens sequenced in many major countries, the WHO said. “It is expected to quickly prevail over other options and become the dominant circulation pathway in the coming months,” the UN health agency said in its weekly epidemiological update.

Of the three other affected coronavirus variants (VOCs), Alpha, which was first detected in the UK, to 180 areas (six compared to the previous week), Beta, which was first seen in South Africa, at 130 (up to seven) and Gamma. Reported. First discovered in Brazil, in the year 78 (with three). According to the SARS-CoV-2 sequence presented to the global scientific initiative GISAID in the four weeks ending July 20, the prevalence of Delta in some countries is more than 75%.

These include Australia, Bangladesh, Botswana, United Kingdom, China, Denmark, India, Indonesia, Israel, Portugal, Russia, Singapore, and South Africa. “Increasing evidence supports the increased portability of the Delta variant compared to non-VOC. However, the exact mechanism for increasing portability remains unclear,” WHO said.

Cases up to 12%

The Geneva-based organization said a total of 3.4 million new cases of Covid-19 had been registered in the week leading up to July 18, 12 percent more than the previous week. “At this rate, the cumulative number from cases reported worldwide is expected to exceed 200 million in the next three weeks,” the WHO said.

The organization says the increase in worldwide transmission appears to be due to four factors: more infectious variants, Relaxation of public health policies, increasing social mix, and large numbers of unvaccinated people. The number of cases increased by 30 percent in the WHO region in the Western Pacific and 21 percent in the European region.